Literature DB >> 20222916

Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia.

M M Walker1, S S Salehian, C E Murray, A Rajendran, J M Hoare, R Negus, N Powell, N J Talley.   

Abstract

BACKGROUND: Allergy and functional gastrointestinal disorders have been associated with eosinophilia in duodenal mucosa. AIM: To assess the prevalence of eosinophilia in duodenal biopsies of patients attending for oesophogastroduodenoscopy and delineate associated clinical conditions.
METHODS: A total of 155 patients (mean age 55 years, 59% women) with normal duodenal biopsies were randomly selected for audit from histopathology files. Eosinophil counts in five high power fields (HPFs) were assessed. Records were analysed for symptoms, diagnosis and medications; patients were divided into five groups based on upper gastrointestinal (UGI) symptom profiles, including a control group of those without predominant UGI symptoms. The prevalence of duodenal eosinophilia (defined as >22/5HPFs a priori) was calculated.
RESULTS: In the control group, the mean duodenal eosinophil count was 15/5HPFs; prevalence of duodenal eosinophilia was 22.5%. In postprandial distress syndrome (PDS), both mean eosinophil counts (20.2/5HPF, P < 0.04) and prevalence of duodenal eosinophilia (47.3%, P < 0.04) were significantly higher. Duodenal eosinophilia was significantly associated with allergy (OR 5.04, 95% CI 2.12-11.95, P < 0.001). There was no association with irritable bowel syndrome or medications.
CONCLUSIONS: Subtle duodenal eosinophilia is relatively common in routine oesophogastroduodenoscopy and previously overlooked; it is associated with allergy and may indicate a hypersensitivity mechanism in some patients with PDS including early satiety.

Entities:  

Mesh:

Year:  2010        PMID: 20222916     DOI: 10.1111/j.1365-2036.2010.04282.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  33 in total

Review 1.  Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman; Jennifer M Colombo; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

2.  Women and functional dyspepsia.

Authors:  Kate Napthali; Natasha Koloski; Marjorie M Walker; Nicholas J Talley
Journal:  Womens Health (Lond)       Date:  2016-02-22

3.  Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia.

Authors:  Carla Cirillo; Talat Bessissow; An-Sofie Desmet; Hanne Vanheel; Jan Tack; Pieter Vanden Berghe
Journal:  Am J Gastroenterol       Date:  2015-06-16       Impact factor: 10.864

4.  Decreased Number of Duodenal Endocrine Cells with Unaltered Serotonin-Containing Cells in Functional Dyspepsia.

Authors:  Anne-Barbara Witte; Marjorie M Walker; Nicholas J Talley; Pertti Aro; Jukka Ronkainen; Vincenzo Marrazzo; Lars Agréus; Peter T Schmidt
Journal:  Am J Gastroenterol       Date:  2016-12       Impact factor: 10.864

5.  The challenges of evolving Rome criteria for functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-14

Review 6.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

7.  The Altered Mucosal Barrier Function in the Duodenum Plays a Role in the Pathogenesis of Functional Dyspepsia.

Authors:  Keishi Komori; Eikichi Ihara; Yosuke Minoda; Haruei Ogino; Taisuke Sasaki; Minako Fujiwara; Yoshinao Oda; Yoshihiro Ogawa
Journal:  Dig Dis Sci       Date:  2019-01-23       Impact factor: 3.199

Review 8.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

Review 9.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

Review 10.  Changes in gastrointestinal tract function and structure in functional dyspepsia.

Authors:  Hanne Vanheel; Ricard Farré
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-15       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.